<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2370" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38725874</article-id><article-id pub-id-type="pmc">PMC11079435</article-id>
<article-id pub-id-type="doi">10.1002/deo2.370</article-id><article-id pub-id-type="publisher-id">DEO2370</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Visibility of esophageal squamous cell carcinoma under iodine staining on texture and color enhancement imaging</article-title><alt-title alt-title-type="left-running-head">KATO <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo2370-cr-0001" contrib-type="author"><name><surname>Kato</surname><given-names>Tsunetaka</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2529-2463</contrib-id><xref rid="deo2370-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0002" contrib-type="author" corresp="yes"><name><surname>Hikichi</surname><given-names>Takuto</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9815-1557</contrib-id><xref rid="deo2370-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>takuto@fmu.ac.jp</email></address></contrib><contrib id="deo2370-cr-0003" contrib-type="author"><name><surname>Nakamura</surname><given-names>Jun</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6006-1778</contrib-id><xref rid="deo2370-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0004" contrib-type="author"><name><surname>Hashimoto</surname><given-names>Minami</given-names></name><xref rid="deo2370-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0005" contrib-type="author"><name><surname>Kobashi</surname><given-names>Ryoichiro</given-names></name><xref rid="deo2370-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0006" contrib-type="author"><name><surname>Yanagita</surname><given-names>Takumi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1236-857X</contrib-id><xref rid="deo2370-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0007" contrib-type="author"><name><surname>Takagi</surname><given-names>Tadayuki</given-names></name><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0008" contrib-type="author"><name><surname>Suzuki</surname><given-names>Rei</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4049-0484</contrib-id><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0009" contrib-type="author"><name><surname>Sugimoto</surname><given-names>Mitsuru</given-names></name><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0010" contrib-type="author"><name><surname>Asama</surname><given-names>Hiroyuki</given-names></name><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0011" contrib-type="author"><name><surname>Sato</surname><given-names>Yuki</given-names></name><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0012" contrib-type="author"><name><surname>Shioya</surname><given-names>Yasuo</given-names></name><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2370-cr-0013" contrib-type="author"><name><surname>Kobayakawa</surname><given-names>Masao</given-names></name><xref rid="deo2370-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo2370-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo2370-cr-0014" contrib-type="author"><name><surname>Ohira</surname><given-names>Hiromasa</given-names></name><xref rid="deo2370-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="deo2370-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Endoscopy</named-content>
<institution>Fukushima Medical University Hospital</institution>
<named-content content-type="country-part">Fukushima</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo2370-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>Fukushima Medical University School of Medicine</institution>
<named-content content-type="country-part">Fukushima</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo2370-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Medical Research Center</named-content>
<institution>Fukushima Medical University</institution>
<named-content content-type="country-part">Fukushima</named-content>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Takuto Hikichi, Department of Endoscopy, Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima City, Fukushima, 960&#x02013;1295, Japan.<break/> Email: <email>takuto@fmu.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="135">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e370</elocation-id><history>
<date date-type="rev-recd"><day>04</day><month>4</month><year>2024</year></date>
<date date-type="received"><day>31</day><month>1</month><year>2024</year></date>
<date date-type="accepted"><day>06</day><month>4</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Authors. <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e370.pdf"/><abstract><title>Abstract</title><sec id="deo2370-sec-0010"><title>Objective</title><p>Iodine staining on white light imaging (WLI) is the gold standard for detecting and demarcating esophageal squamous cell carcinoma (ESCC). We examined the effects of texture and color enhancement imaging (TXI) on improving the endoscopic visibility of ESCC under iodine staining.</p></sec><sec id="deo2370-sec-0020"><title>Methods</title><p>Twenty ESCC lesions that underwent endoscopic submucosal dissection were retrospectively included. The color difference between ESCC and the surrounding mucosa (<italic toggle="yes">&#x00394;E</italic>e) on WLI, TXI, and narrow&#x02010;band imaging was assessed, and <italic toggle="yes">&#x00394;E</italic>e under 1% iodine staining on WLI and TXI. Furthermore, the visibility grade determined by endoscopists was evaluated on each imaging.</p></sec><sec id="deo2370-sec-0030"><title>Result</title><p>The median <italic toggle="yes">&#x00394;E</italic>e was greater on TXI than on WLI (14.53 vs. 10.71, respectively; <italic toggle="yes">p</italic> &#x0003c; 0.005). Moreover, the median <italic toggle="yes">&#x00394;E</italic>e on TXI under iodine staining was greater than the median <italic toggle="yes">&#x00394;E</italic>e on TXI and narrow&#x02010;band imaging (39.20 vs. 14.53 vs. 16.42, respectively; <italic toggle="yes">p</italic> &#x0003c; 0.005 for both). A positive correlation in <italic toggle="yes">&#x00394;E</italic>e under iodine staining was found between TXI and WLI (correlation coefficient = 0.61, <italic toggle="yes">p</italic> &#x0003c; 0.01). Moreover, <italic toggle="yes">&#x00394;E</italic>e under iodine staining on TXI in each lesion was greater than the corresponding <italic toggle="yes">&#x00394;E</italic>e on WLI. The visibility grade assessed by endoscopists on TXI was also significantly greater than that on WLI under iodine staining (<italic toggle="yes">p</italic> &#x0003c; 0.01).</p></sec><sec id="deo2370-sec-0040"><title>Conclusions</title><p>The visibility of ESCC after iodine staining was greater on TXI than on WLI.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2370-kwd-0001">color difference</kwd><kwd id="deo2370-kwd-0002">endoscopic diagnosis</kwd><kwd id="deo2370-kwd-0003">esophageal squamous cell carcinoma</kwd><kwd id="deo2370-kwd-0004">iodine staining</kwd><kwd id="deo2370-kwd-0005">texture and color enhancement imaging</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="4"/><page-count count="9"/><word-count count="5523"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo2370-sec-0050"><title>INTRODUCTION</title><p>Among esophageal cancers, squamous cell carcinoma (SCC) accounts for 90% in East Asia.<xref rid="deo2370-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="deo2370-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Esophageal SCC (ESCC) at cStage 0 is indicated for endoscopic resection, and sufficient outcomes have been achieved with endoscopic resection.<xref rid="deo2370-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo2370-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Iodine staining is the gold standard for the detection and border demarcation of cStage 0 ESCC.<xref rid="deo2370-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo2370-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="deo2370-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="deo2370-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo2370-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="deo2370-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo2370-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> However, iodine staining of the esophageal mucosa may cause adverse events, such as chest pain, laryngitis, pneumonia, and gastric mucosal injury.<xref rid="deo2370-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo2370-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="deo2370-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo2370-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> For patients at high risk for ESCC, endoscopic examination is often performed under sedation or through image&#x02010;enhanced endoscopy, such as narrow&#x02010;band imaging (NBI), to avoid the use of iodine staining. Although iodine staining has been used at a concentration of approximately 1% in recent years, adverse events still occur frequently, making the use of a lower concentration of iodine staining potentially desirable.<xref rid="deo2370-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p><p>Recently, a new image&#x02010;enhanced endoscopy technique, texture and color enhancement imaging (TXI), has been developed.<xref rid="deo2370-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> TXI is designed to emphasize the three image elements of white light imaging (WLI): texture, color, and brightness. Furthermore, TXI has two modes. TXI has been reported to improve the visibility of gastrointestinal lesions by enhancing mucosal structures in real&#x02010;time during endoscopic observation.<xref rid="deo2370-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> The effectiveness of TXI compared with WLI in improving the visibility of gastric and colorectal cancer has been reported.<xref rid="deo2370-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="deo2370-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="deo2370-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="deo2370-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="deo2370-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="deo2370-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Improved visibility on TXI for ESCC has also been reported<xref rid="deo2370-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>; however, the effects of TXI when iodine staining is used for ESCC have not been evaluated. Here, we preliminary examined the effects of TXI on improving the endoscopic visibility of ESCC under 1% iodine staining.</p></sec><sec id="deo2370-sec-0060"><title>METHODS</title><sec id="deo2370-sec-0070"><title>Study design and patients</title><p>We retrospectively collected data on patients with ESCC who underwent endoscopic submucosal dissection (ESD) at Fukushima Medical University Hospital from March 2022 to September 2022. Patients who did not undergo endoscopic examinations with EVIS X1 (Olympus Medical Systems Corp.) were excluded. We targeted a minimum of 20 cases as a pilot study.</p><p>This study was conducted according to the Guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Fukushima Medical University (approval number: 2020&#x02013;146).</p></sec><sec id="deo2370-sec-0080"><title>Endoscopic imaging and ESD for ESCC in the clinical setting</title><p>According to the Japanese Guidelines for the Treatment of Esophageal Cancer,<xref rid="deo2370-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> ESCCs that appeared to be within the mucosa, without lymph node or distant metastasis, were indicated for ESD. If the patients did not have an allergy to iodine, precise observation with iodine staining was performed in all cases just before ESD. Endoscopic observation and ESD procedures were performed by five expert endoscopists who were board&#x02010;certified fellows of the Japan Gastroenterological Endoscopy Society.</p><p>GIF&#x02010;EZ1500 or GIF&#x02010;XZ1200 (Olympus Medical Systems Corp.) with the EVIS X1 endoscope system was used. Three types of images, WLI (Figure&#x000a0;<xref rid="deo2370-fig-0001" ref-type="fig">1a</xref>), TXI (Figure&#x000a0;<xref rid="deo2370-fig-0001" ref-type="fig">1b</xref>), and NBI (Figure&#x000a0;<xref rid="deo2370-fig-0001" ref-type="fig">1c</xref>), were taken, each with 4&#x02013;10 frames. For TXI, only TXI Mode 1 was used. Following this, a 1% iodine solution was sprayed over the entire lesion using a catheter. Endoscopic image enhancement was set to B8 for WLI and NBI. Additionally, TXI Mode1 was set to strong enhancement. WLI and TXI images were taken within one minute after iodine staining, 4&#x02013;10 frames at a time (Figures&#x000a0;<xref rid="deo2370-fig-0001" ref-type="fig">1d,e</xref>). Therefore, the pink&#x02010;color sign was not evaluated. All endoscopic images were stored in Solemio ENDO (Olympus Medical Systems Corp.).</p><fig position="float" fig-type="FIGURE" id="deo2370-fig-0001"><label>FIGURE 1</label><caption><p>A representative case of esophageal squamous cell carcinoma.</p><p>WLI showed a red depressed lesion with less than 1/2 circumference in the middle of the thoracic esophagus (a). The same lesion as Figure&#x000a0;<xref rid="deo2370-fig-0001" ref-type="fig">1a</xref> was imaged using TXI Mode 1 (b) and NBI (c). Furthermore, WLI (d) and TXI (e) images were taken after spraying with 1% iodine solution. The histopathological findings of the ESD specimen showed SCC with a depth of the MM and a lesion length diameter of 26 mm.</p><p>WLI, white light imaging; TXI, texture, and color enhancement imaging; NBI, narrow&#x02010;band imaging; ESD, endoscopic submucosal dissection; MM, muscularis mucosae; SCC, squamous cell carcinoma.</p></caption><graphic xlink:href="DEO2-5-e370-g004" position="anchor" id="jats-graphic-1"/></fig><p>According to the Japanese Classification of Esophageal Cancer, the histopathological features of resected specimens, including macroscopic type, lesion diameter, lesion depth, lymphatic invasion, venous invasion, horizontal margin, and vertical margin, were evaluated.<xref rid="deo2370-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>
</p></sec><sec id="deo2370-sec-0090"><title>Evaluation of color difference</title><p>The c (CIE) LAB color system recommended by the CIE in 1976 as a method for quantifying color<xref rid="deo2370-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> was adopted in this study. The concept of a &#x0201c;color space&#x0201d; comprised the <italic toggle="yes">L*</italic>, <italic toggle="yes">a*</italic>, and <italic toggle="yes">b*</italic> axes. <italic toggle="yes">L*</italic> represents &#x0201c;lightness,&#x0201d; indicated by black on white (range, 0&#x02013;100). <italic toggle="yes">a*</italic> and <italic toggle="yes">b*</italic> represent &#x0201c;chromaticity,&#x0201d; respectively. Green represents the negative direction of <italic toggle="yes">a*</italic>, whereas red represents the positive direction (range, &#x02212;60&#x02013;60). Blue represents the negative direction of <italic toggle="yes">b</italic>*, whereas yellow represents the positive direction (range, &#x02212;60&#x02013;60). However, because endoscopic image colors are output in the red, green, and blue (RGB) color system, <italic toggle="yes">L*a*b*</italic> values were calculated by converting RGB color system values to CIE LAB color system values based on the conversion formula of Mokrzycki et&#x000a0;al.<xref rid="deo2370-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Color difference (<italic toggle="yes">&#x00394;E</italic>) is a concept that quantifies the difference between two colors and can be expressed as the distance between two colors in the &#x0201c;color space.&#x0201d;</p><p>Based on a previous theory, <italic toggle="yes">&#x00394;E</italic> was measured from endoscopic images as follows: one endoscopist (Tsunetaka Kato) selected one image each from the endoscopic images that approximated the distance and angle between the lesion and endoscope. The images were placed on image analysis software (Adobe Photoshop Elements 12; Adobe Systems), and five sample points were randomly selected from each of the ESCC and surrounding mucosa (10 sample points in total) as a pair (Figure&#x000a0;<xref rid="deo2370-fig-0002" ref-type="fig">2a,b</xref>). The sample point selected was within 2 mm of the borderline between the ESCC and surrounding mucosa, which was determined based on the pathology results of ESD. The RGB values of each sample point were converted to <italic toggle="yes">L*a*b*</italic> values using a conversion formula. Using the <italic toggle="yes">L*a*b*</italic> values (<italic toggle="yes">L*y, a* y, b* y</italic>) of the ESCC and the <italic toggle="yes">L*a*b*</italic> values (<italic toggle="yes">L*y, a* y, b* y</italic>) of the surrounding mucosa, <italic toggle="yes">&#x00394;E</italic> between the paired ESCC and surrounding mucosa was calculated using the following formula: <italic toggle="yes">&#x00394;E</italic> = &#x0221a; (<italic toggle="yes">L*<sub>x</sub>
</italic> &#x02212; <italic toggle="yes">L*<sub>y</sub>
</italic>)<sup>2</sup> + (<italic toggle="yes">a*<sub>x</sub>
</italic> &#x02212; <italic toggle="yes">a*<sub>y</sub>
</italic>)<sup>2</sup> + (<italic toggle="yes">b*<sub>x</sub>
</italic> &#x02212; <italic toggle="yes">b*<sub>y</sub>
</italic>)<sup>2</sup>
</p><fig position="float" fig-type="FIGURE" id="deo2370-fig-0002"><label>FIGURE 2</label><caption><p>Selection of sample points for <italic toggle="yes">&#x00394;E</italic>
<sub>e</sub> calculation.</p><p>Based on the histopathological results of ESD, the border between the ESCC and surrounding mucosa is defined by a white line on the endoscopic image (a). Next, five sample points are randomly selected from the ESCC and surrounding mucosa, each in pairs (b).</p><p>
<italic toggle="yes">&#x00394;E</italic>e, the color difference between the esophageal squamous cell carcinoma and the surrounding mucosa; ESD, endoscopic submucosal dissection; ESCC, esophageal squamous cell carcinoma.</p></caption><graphic xlink:href="DEO2-5-e370-g003" position="anchor" id="jats-graphic-3"/></fig><p>The <italic toggle="yes">&#x00394;E</italic> average at 5 points calculated here was defined as the <italic toggle="yes">&#x00394;E</italic>e. Moreover, the difference in brightness between the ESCC and surrounding mucosa was defined as &#x0201c;<italic toggle="yes">&#x00394;L</italic>* = <italic toggle="yes">L*x &#x02212; L*y</italic>&#x0201d; and the difference in chromaticity as &#x0201c;<italic toggle="yes">&#x00394;a</italic>* = <italic toggle="yes">a*x &#x02212; a*y</italic>&#x0201d; and &#x0201c;<italic toggle="yes">&#x00394;b</italic>* = <italic toggle="yes">b*x &#x02212; b*y</italic>&#x0201d; were defined.</p></sec><sec id="deo2370-sec-0100"><title>Outcomes</title><p>Clinical data were retrospectively collected from electronic medical records and endoscopic databases. The following outcomes were assessed: <italic toggle="yes">&#x00394;Ee</italic> on WLI, TXI, and NBI, and <italic toggle="yes">&#x00394;Ee</italic> under iodine staining on WLI and TXI; visibility grade under iodine staining assessed by endoscopists on TXI and WLI; changes in <italic toggle="yes">L*a*b*</italic> values after iodine staining in the ESCC and surrounding mucosa localities; and changes in <italic toggle="yes">L*a*b*</italic> values under iodine staining between the ESCC and surrounding mucosa. The visibility grade was evaluated under discussion by two endoscopists (Tsunetaka Kato and Ryoichiro Kobashi) for the same endoscopic images before <italic toggle="yes">&#x00394;E</italic>e analysis. The visibility grade was defined as follows (Figure <xref rid="deo2370-supitem-0001" ref-type="supplementary-material">S1</xref>): Grade 1 when ESCC detection and border demarcation are difficult to perform, Grade 2 when ESCC detection is possible but border demarcation is difficult, Grade 3 when ESCC detection is possible but border demarcation is partially difficult, Grade 4 when ESCC detection is possible and border demarcation is generally possible, and Grade 5 when both ESCC detection and border demarcation are easy.</p></sec><sec id="deo2370-sec-0110"><title>Statistical analysis</title><p>Continuous values are reported as medians with 95% confidence intervals (CIs), and discrete values are reported as medians with ranges. The difference in median <italic toggle="yes">&#x00394;Ee</italic> between WLI, NBI, TXI, and WLI and TXI under iodine staining was subjected to a multiple comparison test (Bonferroni method). Lesion factors associated with increased <italic toggle="yes">&#x00394;Ee</italic> were tested using the Mann&#x02013;Whitney U test. The visibility grade accessed by endoscopists was evaluated using the chi&#x02010;square test or m &#x000d7; n contingency table, and a comparison of <italic toggle="yes">L*a*b*</italic> values under iodine staining on WLI and TXI was analyzed using the Wilcoxon signed&#x02010;rank sum test. Pearson's correlation coefficient test was used to analyze the correlation of <italic toggle="yes">&#x00394;Ee</italic> under iodine staining on TXI and WLI. The correlation of <italic toggle="yes">&#x00394;Ee</italic> and the correlation of visibility grades under iodine staining on WLI and TXI were calculated using Spearman's rank correlation coefficient. The difference of <italic toggle="yes">p</italic>&#x02010;value &#x0003c; 0.005 for the subjected to a multiple comparison test (Bonferroni method) and <italic toggle="yes">p</italic>&#x02010;value &#x0003c; 0.05 otherwise was considered statistically significant, and statistically analyzed using the Statistical Package for the Social Sciences (version 21; IBM Corp).</p></sec></sec><sec id="deo2370-sec-0120"><title>RESULTS</title><sec id="deo2370-sec-0130"><title>Patients and lesion characteristics</title><p>Twenty lesions from the 20 patients who underwent ESD for ESCC during the study enrollment period were analyzed (Table&#x000a0;<xref rid="deo2370-tbl-0001" ref-type="table">1</xref>). The median age of the patients was 71 years, and 90% were male. Lesion color was red, isochromatic, and white in 65%, 20%, and 15% of the cases, respectively, and lesion circumference less than 1/2 circumference was observed in 95% of the cases. All analyzed ESCCs were successfully treated with ESD and resected en bloc.</p><table-wrap position="float" id="deo2370-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Patient characteristics at baseline before endoscopic submucosal dissection of esophageal squamous cell carcinoma, and histopathological findings of resected specimens (<italic toggle="yes">n</italic> = 20).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><tbody><tr><td align="left" rowspan="1" colspan="1">Median age, (range), years</td><td align="char" rowspan="1" colspan="1">71 (60&#x02013;80)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Male</td><td align="char" rowspan="1" colspan="1">18 (90)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Female</td><td align="char" rowspan="1" colspan="1">2 (10)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lesion location, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Upper thoracic esophagus</td><td align="char" rowspan="1" colspan="1">1 (5)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Middle thoracic esophagus</td><td align="char" rowspan="1" colspan="1">14 (70)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Lower thoracic esophagus</td><td align="char" rowspan="1" colspan="1">5 (25)</td></tr><tr><td align="left" rowspan="1" colspan="1">Macroscopic type, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Slightly depressed</td><td align="char" rowspan="1" colspan="1">12 (60)</td></tr><tr><td align="left" rowspan="1" colspan="1">Flat</td><td align="char" rowspan="1" colspan="1">5 (25)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Slightly elevated</td><td align="char" rowspan="1" colspan="1">3 (15)</td></tr><tr><td align="left" rowspan="1" colspan="1">Preprocedural lesion depth estimation, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Mucosa</td><td align="char" rowspan="1" colspan="1">60 (100)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lesion circumference, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#x0003c;1/4</td><td align="char" rowspan="1" colspan="1">9 (45)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#x02265;1/4&#x02013;&#x0003c;1/2</td><td align="char" rowspan="1" colspan="1">10 (50)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#x02265;1/2</td><td align="char" rowspan="1" colspan="1">1 (5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lesion color compared to the surrounding mucosa, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Red</td><td align="char" rowspan="1" colspan="1">13 (65)</td></tr><tr><td align="left" rowspan="1" colspan="1">Isochromatic</td><td align="char" rowspan="1" colspan="1">4 (20)</td></tr><tr><td align="left" rowspan="1" colspan="1">White</td><td align="char" rowspan="1" colspan="1">3 (15)</td></tr><tr><td align="left" rowspan="1" colspan="1">Histopathological findings of resected specimens with ESD</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Lesion diameter, median (range), mm</td><td align="char" rowspan="1" colspan="1">14.5 (5&#x02013;49)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lesion depth, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">EP</td><td align="char" rowspan="1" colspan="1">6 (30)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">LPM</td><td align="char" rowspan="1" colspan="1">10 (50)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">MM</td><td align="char" rowspan="1" colspan="1">2 (10)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">SM1</td><td align="char" rowspan="1" colspan="1">2 (10)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphatic invasion, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">1 (5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Venous invasion, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Horizontal margin positive, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Vertical margin positive, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="deo2370-tbl1-note-0001"><p>Abbreviations: EP, epithelium; ESD, endoscopic submucosal dissection; LPM, lamina propria mucosae; MM, muscularis mucosae; SM1, invasion depth &#x0003c;200&#x000b5;m from the muscularis mucosa.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2370-sec-0140"><title>
<italic toggle="yes">&#x00394;E</italic>e in each image</title><p>No difference in the median <italic toggle="yes">&#x00394;E</italic>e was observed between TXI and NBI; however, the median <italic toggle="yes">&#x00394;E</italic>e on both images was greater than that on WLI (14.53 vs. 16.42 vs. 10.71, respectively; <italic toggle="yes">p</italic> &#x0003c; 0.005 for both; Table&#x000a0;<xref rid="deo2370-tbl-0002" ref-type="table">2</xref> and Figure&#x000a0;<xref rid="deo2370-fig-0003" ref-type="fig">3</xref>). The median <italic toggle="yes">&#x00394;E</italic>e under iodine staining on WLI was greater than <italic toggle="yes">&#x00394;E</italic>e on WLI (26.91 vs. 10.71, respectively; <italic toggle="yes">p</italic> &#x0003c; 0.005), and the median <italic toggle="yes">&#x00394;E</italic>e on TXI under iodine staining was greater than <italic toggle="yes">&#x00394;E</italic>e on TXI and NBI (39.20 vs. 14.53 vs. 16.42, respectively; <italic toggle="yes">p</italic> &#x0003c; 0.005 for both; Figure&#x000a0;<xref rid="deo2370-fig-0003" ref-type="fig">3</xref>). A positive correlation of <italic toggle="yes">&#x00394;E</italic>e under iodine staining was observed on TXI and WLI (correlation coefficient = 0.61, 95% CI: 0.23&#x02013;0.83, <italic toggle="yes">p</italic> &#x0003c; 0.01), and <italic toggle="yes">&#x00394;E</italic>e on TXI in each case was greater than the corresponding <italic toggle="yes">&#x00394;E</italic>e under iodine staining on WLI (Figure <xref rid="deo2370-supitem-0002" ref-type="supplementary-material">S2</xref>). None of the lesion factors, including macroscopic type, lesion diameter, lesion depth, lesion circumference, or lesion color affected the <italic toggle="yes">&#x00394;E</italic>e under iodine staining on TXI (Table&#x000a0;<xref rid="deo2370-tbl-0003" ref-type="table">3</xref>).</p><table-wrap position="float" id="deo2370-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Median color difference value between esophageal squamous cell carcinoma and surrounding mucosa (<italic toggle="yes">n</italic> = 20).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">&#x00394;Ee</italic>, median (95% CI)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">No staining</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">WLI</td><td align="char" rowspan="1" colspan="1">10.71 (9.60&#x02013;13.32)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">NBI</td><td align="char" rowspan="1" colspan="1">16.42 (15.04&#x02013;18.97)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">TXI</td><td align="char" rowspan="1" colspan="1">14.53 (12.69&#x02013;19.05)</td></tr><tr><td align="left" rowspan="1" colspan="1">With iodine staining</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">iWLI</td><td align="char" rowspan="1" colspan="1">26.91 (24.27&#x02013;30.24)</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">iTXI</td><td align="char" rowspan="1" colspan="1">39.20 (38.91&#x02013;47.26)</td></tr></tbody></table><table-wrap-foot><fn id="deo2370-tbl2-note-0001"><p>Abbreviations: <italic toggle="yes">&#x00394;Ee</italic>, color difference between esophageal squamous cell carcinoma and surrounding mucosa; CI, confidence interval; iTXI, TXI image under iodine staining; iWLI, WLI image under iodine staining; NBI, narrow band imaging; TXI, texture and color enhancement imaging; WLI, white light imaging.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><fig position="float" fig-type="FIGURE" id="deo2370-fig-0003"><label>FIGURE 3</label><caption><p>The color difference between the esophageal squamous cell carcinoma and surrounding mucosa (<italic toggle="yes">&#x00394;E</italic>
<sub>e</sub>).</p><p>
<italic toggle="yes">&#x00394;E</italic>e in iTXI was greater than that in iWLI; <italic toggle="yes">&#x00394;E</italic>e in iWLI was greater than that in WLI; and <italic toggle="yes">&#x00394;E</italic>e in iTXI was greater than that in TXI. No significant difference in <italic toggle="yes">&#x00394;E</italic>e was observed between TXI and NBI; however, TXI had a greater <italic toggle="yes">&#x00394;E</italic>e than WLI. <italic toggle="yes">&#x00394;Ee</italic> in both iWLI and iTXI was greater than that in NBI.</p><p>An adjusted two&#x02010;sided <italic toggle="yes">p</italic>&#x02010;value threshold of 0.005 was used using the Bonferroni method.</p><p>
<italic toggle="yes">&#x00394;E</italic>e, the color difference between the esophageal squamous cell carcinoma and surrounding mucosa; TXI, texture, and color enhancement imaging; WLI, white light imaging; NBI, narrow&#x02010;band imaging; iTXI, TXI image under iodine staining; iWLI, WLI image under iodine staining; n.s., not significant</p></caption><graphic xlink:href="DEO2-5-e370-g001" position="anchor" id="jats-graphic-5"/></fig><table-wrap position="float" id="deo2370-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Median color difference values in texture and color enhancement imaging with iodine staining according to lesion factors (<italic toggle="yes">n</italic> = 20).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">&#x00394;Ee</italic>, median (95% CI)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Macroscopic type</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Slight depressed (<italic toggle="yes">n</italic> = 12)</td><td align="left" rowspan="1" colspan="1">39.20 (37.96&#x02013;49.60)</td><td align="left" rowspan="1" colspan="1">0.64</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Flat or slightly elevated (<italic toggle="yes">n</italic> = 8)</td><td align="left" rowspan="1" colspan="1">40.29 (35.93&#x02013;48.15)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Lesion diameter, mm</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#x0003c; 15 (<italic toggle="yes">n</italic> = 10)</td><td align="left" rowspan="1" colspan="1">37.44 (34.92&#x02013;46.67)</td><td align="left" rowspan="1" colspan="1">0.64</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#x02265; 15 (<italic toggle="yes">n</italic> = 10)</td><td align="left" rowspan="1" colspan="1">47.61 (39.50&#x02013;51.26)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Lesion depth, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">EP to LPM (<italic toggle="yes">n</italic> = 16)</td><td align="left" rowspan="1" colspan="1">41.86 (39.40&#x02013;48.54)</td><td align="left" rowspan="1" colspan="1">0.26</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">MM to SM1 (<italic toggle="yes">n</italic> = 4)</td><td align="left" rowspan="1" colspan="1">35.17 (28.86&#x02013;50.23)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cancer circumference</td><td colspan="2" align="left" rowspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#x0003c; 1/4 (<italic toggle="yes">n</italic> = 9)</td><td align="left" rowspan="1" colspan="1">38.22 (35.20&#x02013;47.90)</td><td align="left" rowspan="1" colspan="1">0.52</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">&#x02265; 1/4 (<italic toggle="yes">n</italic> = 11)</td><td align="left" rowspan="1" colspan="1">44.46 (38.65&#x02013;50.03)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Lesion color compared to the surrounding mucosa</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Red (<italic toggle="yes">n</italic> = 13)</td><td align="left" rowspan="1" colspan="1">36.67 (36.89&#x02013;48.79)</td><td align="left" rowspan="1" colspan="1">0.66</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Isochromatic/ white (<italic toggle="yes">n</italic> = 7)</td><td align="left" rowspan="1" colspan="1">43.91 (38.44&#x02013;48.62)</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="deo2370-tbl3-note-0001"><p>Abbreviations: <italic toggle="yes">&#x00394;Ee</italic>, color difference between esophageal squamous cell carcinoma and surrounding mucosa; CI, confidence interval; EP, epithelium; LPM, lamina propria mucosae; MM, muscularis mucosae; SM1, invasion depth &#x0003c;200 &#x000b5;m from the muscularis mucosa.</p></fn><fn id="deo2370-tbl3-note-0002"><p>
<italic toggle="yes">p</italic>&#x02010;Value was calculated by the Mann&#x02013;Whitney U test.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2370-sec-0150"><title>Visibility evaluation by endoscopists</title><p>In all lesions, the visibility grade evaluated under iodine staining on both TXI and WLI was&#x02265;4. However, the number of lesions with visibility grade 5 under iodine staining was 19 on TXI and 7 on WLI, with a significant difference (<italic toggle="yes">p</italic> &#x0003c; 0.01; Table&#x000a0;<xref rid="deo2370-tbl-0004" ref-type="table">4</xref>). The visibility grades evaluated under iodine staining on TXI were significantly greater than those evaluated under iodine staining on WLI (Table&#x000a0;<xref rid="deo2370-tbl-0004" ref-type="table">4</xref>). No difference in visibility grade distributions was observed among the evaluations on WLI, TXI, and NBI. A positive correlation was observed between <italic toggle="yes">&#x00394;Ee</italic> and subjective visibility scores by the endoscopist under iodine staining on a pooled analysis of WLI and TXI (correlation coefficient = 0.68, 95% CI: 0.35&#x02013;0.77, <italic toggle="yes">p</italic> &#x0003c; 0.01; Figure <xref rid="deo2370-supitem-0003" ref-type="supplementary-material">S3</xref>).</p><table-wrap position="float" id="deo2370-tbl-0004" content-type="TABLE"><label>TABLE 4</label><caption><p>Visibility grade accessed by endoscopists (<italic toggle="yes">n</italic> = 20)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Grade 1</th><th align="left" rowspan="1" colspan="1">Grade 2</th><th align="left" rowspan="1" colspan="1">Grade 3</th><th align="left" rowspan="1" colspan="1">Grade 4</th><th align="left" rowspan="1" colspan="1">Grade 5</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" colspan="7" rowspan="1">No staining</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">WLI</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0</td><td rowspan="3" align="left" colspan="1">0.14<xref rid="deo2370-tbl4-note-0004" ref-type="table-fn">
<sup>*</sup>
</xref>
</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">NBI</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">TXI</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" colspan="7" rowspan="1">With iodine staining</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">iWLI</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">7</td><td rowspan="2" align="left" colspan="1">&#x0003c;0.01<xref rid="deo2370-tbl4-note-0005" ref-type="table-fn">
<sup>**</sup>
</xref>
</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">iTXI</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">19</td></tr></tbody></table><table-wrap-foot><fn id="deo2370-tbl4-note-0001"><p>Abbreviations: iTXI, TXI image under iodine staining; iWLI, WLI image under iodine staining; NBI, narrow band imaging; TXI, texture and color enhancement imaging; WLI, white light imaging.</p></fn><fn id="deo2370-tbl4-note-0002"><p>Values are shown as <italic toggle="yes">n</italic>.</p></fn><fn id="deo2370-tbl4-note-0003"><p>The visibility grade was defined as follows: Grade 5, both detection of the lesions and border demarcation are easy. Grade 4, the lesions can be detected, and border demarcation is generally possible. Grade 3, the lesions can be detected, but border demarcation is difficult in some parts of the lesion. Grade 2, the lesions can be detected, but border demarcation is difficult. Grade 1, both detection of the lesions and border demarcation are difficult.</p></fn><fn id="deo2370-tbl4-note-0004"><label>*</label><p>
<italic toggle="yes">p</italic>&#x02010;Value was calculated by m &#x000d7; n contingency table.</p></fn><fn id="deo2370-tbl4-note-0005"><label>**</label><p>
<italic toggle="yes">p</italic>&#x02010;Values were calculated by Chi&#x02010;square test.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2370-sec-0160"><title>Analysis of <italic toggle="yes">L*a*b*</italic> values under iodine staining</title><p>In the ESCC lesion, the median lightness component <italic toggle="yes">L*</italic> under iodine staining was significantly greater on TXI than on WLI (64.10 vs. 54.19, <italic toggle="yes">p</italic> &#x0003c; 0.01), and the median chromaticity component <italic toggle="yes">a*</italic> under iodine staining was significantly lesser on TXI than on WLI (29.79 vs. 33.90, respectively; <italic toggle="yes">p</italic> &#x0003c; 0.01), whereas the median chromaticity component <italic toggle="yes">b*</italic> under iodine staining did not significantly differ between TXI and WLI (48.60 vs. 49.12, respectively; <italic toggle="yes">p</italic> = 0.30; Figure&#x000a0;<xref rid="deo2370-fig-0004" ref-type="fig">4a</xref>). In the surrounding mucosa, the median of all components of <italic toggle="yes">L*a*b*</italic> values under iodine staining were significantly lesser on TXI than on WLI (<italic toggle="yes">L*</italic>: 34.79 vs. 38.76, <italic toggle="yes">p</italic> &#x0003c; 0.01; <italic toggle="yes">a*</italic>: 16.33 vs. 30.56, <italic toggle="yes">p</italic> &#x0003c; 0.01; <italic toggle="yes">b*</italic>: 24.10 vs. 35.75<italic toggle="yes">, p</italic> &#x0003c; 0.01, respectively; Figure&#x000a0;<xref rid="deo2370-fig-0004" ref-type="fig">4b</xref>). Furthermore, the median <italic toggle="yes">L*a*b*</italic> value under iodine staining of ESCC relative to the surrounding mucosa was significantly greater on TXI than on WLI for all components (<italic toggle="yes">&#x00394;L*</italic>: 27.80 vs. 16.67, <italic toggle="yes">p</italic> &#x0003c; 0.01; <italic toggle="yes">&#x00394;a*</italic>: 12.53 vs. 3.19, <italic toggle="yes">p</italic> &#x0003c; 0.01; <italic toggle="yes">&#x00394;b*</italic>: 22.73 vs. 15.43, <italic toggle="yes">p</italic> &#x0003c; 0.01, respectively; Figure&#x000a0;<xref rid="deo2370-fig-0004" ref-type="fig">4c</xref>).</p><fig position="float" fig-type="FIGURE" id="deo2370-fig-0004"><label>FIGURE 4</label><caption><p>Component&#x02010;specific changes in <italic toggle="yes">&#x00394;L*</italic>, <italic toggle="yes">&#x00394;a*</italic>, and <italic toggle="yes">&#x00394;b*</italic> in esophageal squamous cell carcinoma localization and surrounding mucosa localization, as well as between esophageal squamous cell carcinoma and surrounding mucosa, before and after iodine staining.</p><p>
<italic toggle="yes">L*a*b*</italic> values on WLI and TXI according to components in the esophageal squamous cell carcinoma (a) and surrounding mucosa (b) after iodine staining. After iodine staining, the <italic toggle="yes">L*</italic> component was significantly greater in the esophageal squamous cell carcinoma (ESCC) and significantly lower in the surrounding mucosa than that on WLI for TXI. The <italic toggle="yes">a*</italic> component was significantly lower in both the ESCC and surrounding mucosa than that on WLI for TXI. The <italic toggle="yes">b*</italic> component was significantly lower in the surrounding mucosa than that in WLI for TXI, but not in the ESCC.</p><p>
<italic toggle="yes">L*a*b*</italic> values of esophageal squamous cell carcinoma relative to the surrounding mucosa (c). All components of <italic toggle="yes">L*a*b*</italic> values for ESCC relative to the surrounding mucosa were significantly greater on iTXI than on iWLI.</p><p>ESCC, esophageal squamous cell carcinoma; iTXI, TXI image under iodine staining; iWLI, WLI image under iodine staining; n.s., not significant</p></caption><graphic xlink:href="DEO2-5-e370-g002" position="anchor" id="jats-graphic-7"/></fig></sec></sec><sec id="deo2370-sec-0170"><title>DISCUSSION</title><p>In this study, we evaluated the visibility of ESCC, mainly under iodine staining on WLI and TXI, using <italic toggle="yes">&#x00394;E</italic>e as an objective parameter and the visibility grade assessed by endoscopists. The median <italic toggle="yes">&#x00394;E</italic>e under iodine staining on TXI was significantly greater than that under iodine staining on WLI, and each <italic toggle="yes">&#x00394;E</italic>e value under iodine staining on TXI was greater than the corresponding <italic toggle="yes">&#x00394;E</italic>e value under iodine staining on WLI in all cases. No lesion factors that affect <italic toggle="yes">&#x00394;E</italic>e were found. Furthermore, similar results were obtained in the subjective assessment of the visibility grade. The visibility of ESCC under iodine staining on TXI was correlated with the visibility under iodine staining on WLI and was better, and this was not affected by the lesion background.</p><p>TXI has been reported to be useful for the detection and border demarcation of neoplastic lesions in the stomach and colon.<xref rid="deo2370-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="deo2370-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="deo2370-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="deo2370-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="deo2370-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="deo2370-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="deo2370-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="deo2370-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="deo2370-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="deo2370-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> These reports evaluated visibility using <italic toggle="yes">&#x00394;E</italic>; however, had there been more pairs of lesions and surrounding mucosa in which <italic toggle="yes">&#x00394;E</italic> was measured, they could have been classified as evaluating border demarcation. Abe et&#x000a0;al. evaluated eight pairs of <italic toggle="yes">&#x00394;E</italic> between early gastric cancer and surrounding mucosa and showed that <italic toggle="yes">&#x00394;E</italic> increased under TXI observation, indicating the utility of TXI for border demarcation.<xref rid="deo2370-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Other studies have shown that TXI improves lesion visibility by measuring 1&#x02013;4 pairs of <italic toggle="yes">&#x00394;E</italic> between the lesion and surrounding mucosa or by using subjective visibility scores.<sup>19,22,</sup>
<xref rid="deo2370-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="deo2370-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="deo2370-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="deo2370-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> However, regarding TXI for esophageal lesions, only one ESCC study<xref rid="deo2370-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> and only two studies on Barrett's esophagus<xref rid="deo2370-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="deo2370-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> have been reported. Dobashi et&#x000a0;al. evaluated the <italic toggle="yes">&#x00394;E</italic>e in three pairs between the SCC and surrounding mucosa in the esophagus and pharynx and concluded that <italic toggle="yes">&#x00394;E</italic>e on TXI Mode 1, TXI Mode 2, and NBI was significantly greater than that on WLI.<xref rid="deo2370-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Our present study evaluated the <italic toggle="yes">&#x00394;E</italic>e derived from five pairs randomly selected from the entire ESCC, thereby allowing us to show the usefulness of TXI observation under iodine staining for ESCC border demarcation.</p><p>On TXI observation under iodine staining, the <italic toggle="yes">L*</italic> value between the ESCC and surrounding mucosa increased given that the brightness component <italic toggle="yes">L*</italic> in the ESCC was greater, whereas that in the surrounding mucosa was smaller, than that on WLI. Therefore, the combination of iodine staining and TXI made ESCC brighter and the surrounding mucosa darker, thereby improving visibility. Furthermore, compared to WLI, both <italic toggle="yes">a*</italic> and <italic toggle="yes">b*</italic> chromaticity components between the ESCC and surrounding mucosa on TXI increased, suggesting that the color enhancement function of TXI Mode1 also improved visibility. This study found that all Lab components were lower with TXI than with WLI under iodine staining for the surrounding mucosa and that the <italic toggle="yes">&#x00394;Ee</italic> of WLI and TXI under iodine staining was correlated. This suggests that the use of TXI may have the same effect as that of a high concentration of iodine staining.</p><p>Iodine solution for ESCC diagnosis is used in the range of 0.5%&#x02013;2%, depending on the institution.<xref rid="deo2370-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo2370-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="deo2370-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="deo2370-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>, <xref rid="deo2370-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> The concentration of iodine solution should be as low as possible to prevent adverse events due to irritation.<xref rid="deo2370-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> In a double&#x02010;blind randomized trial, Gotoda et&#x000a0;al. showed that staining with 1% iodine solution had similar diagnostic accuracy to 2% iodine solution and caused less posterior chest pain.<xref rid="deo2370-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> As long as the diagnostic performance is not decreased, a lower concentration of iodine solution is desirable. Although the concentration of iodine solution used in this study was 1%, the positive added visibility values observed here indicated that the use of TXI Mode1 may contribute to the border demarcation of ESCC even with a lower concentration of iodine solution.</p><p>Regarding the WLI, <italic toggle="yes">&#x00394;Ee</italic> values were greater with iodine staining than without, in all cases. However, only one lesion with an unchanged visibility grade on WLI under iodine staining as assessed by endoscopists was observed. Given that the lesion was stained with iodine, it was difficult to evaluate the contrast with the surrounding mucosa. Considering that all images were taken within 1 min after iodine staining, the pink sign and its effect on <italic toggle="yes">&#x00394;Ee</italic> remained unknown. Histologically, this lesion was considered to be caused by the high glycogen content of the mucosa in ESCC, which stained ESCC with iodine. Moreover, the increase in visibility grade from 4 to 5 indicates the borderline between the lesion and surrounding mucosa is clearer, which reduced the endoscopist's concern during ESD marking. Although we could not objectively evaluate the visibility grade and the stress induced by marking during ESD, the endoscopists were certainly concerned when the visibility grade was 4 points.</p><p>This study has several limitations. First, this was a single&#x02010;center, retrospective study involving consecutive patients with a small sample size. Second, <italic toggle="yes">&#x00394;E</italic>e was evaluated on WLI, TXI, and NBI, and the distance and angle to the endoscope were not always the same. An image selection bias may also have been present given that the evaluation was based on the limited number of images obtained. Third, we did not evaluate <italic toggle="yes">&#x00394;Ee</italic> under iodine staining on NBI because it is uncommon to use iodine on NBI for border demarcation between the ESCC and surrounding mucosa. Finally, this study used only a 1% concentration of iodine staining and did not use lower concentrations of iodine.</p><p>In conclusion, under 1% iodine staining, the positive effects of TXI on ESCC border demarcation compared with WLI were demonstrated. Further prospective studies using TXI and lower&#x02010;concentration iodine solutions are required.</p></sec><sec sec-type="COI-statement" id="deo2370-sec-0190"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo2370-sec-0220"><title>ETHICS STATEMENT</title><p>This study was approved by the Ethics Committee of Fukushima Medical University (No. 2020&#x02013;146)</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo2370-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>FIGURE S1</bold> Typical images for visibility grade evaluation.</p><p>Grade 1, lesion detection and border demarcation are difficult (a). Grade 2, lesions can be detected, but border demarcation is difficult (b). Grade 3, lesions can be detected, but border demarcation is difficult in certain parts of the lesion (c). Grade 4, the lesions can be detected, and border demarcation is generally possible (d, e). Grade 5, lesion detection and border demarcation are easy (f). Figure S1a&#x02013;d depicts the endoscopic images obtained through white light imaging, whereas, Figure S1e,f depicts the endoscopic images obtained through white light imaging under iodine staining. The yellow arrow in Figure S1b indicates a lesion.</p></caption><media xlink:href="DEO2-5-e370-s003.tif"/></supplementary-material><supplementary-material id="deo2370-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>FIGURE S2</bold> Correlation between <italic toggle="yes">&#x00394;E</italic>e in iTXI and <italic toggle="yes">&#x00394;E</italic>e in iWLI.</p><p>A positive correlation was observed between <italic toggle="yes">&#x00394;E</italic>e in iTXI and that in iWLI (correlation coefficient [R] = 0.61, 95% confidence interval: 0.23&#x02013;0.83, <italic toggle="yes">p</italic> &#x0003c; 0.01), and <italic toggle="yes">&#x00394;Ee</italic> was greater in iTXI than in iWLI in all cases.</p><p>
<italic toggle="yes">&#x00394;E</italic>e, the color difference between the esophageal squamous cell carcinoma and surrounding mucosa; iTXI, TXI image under iodine staining; iWLI, WLI image under iodine staining.</p></caption><media xlink:href="DEO2-5-e370-s002.TIF"/></supplementary-material><supplementary-material id="deo2370-supitem-0003" position="float" content-type="local-data"><caption><p>
<bold>FIGURE S3</bold> Correlation between the visibility grade and <italic toggle="yes">&#x00394;Ee</italic> containing iWLI and iTXI.</p><p>A positive correlation was observed between the visibility grade and <italic toggle="yes">&#x00394;Ee</italic> containing iWLI and iTXI (correlation coefficient [&#x003c1;], 0.68; 95% confidence interval: 0.35&#x02013;0.77; <italic toggle="yes">p</italic> &#x0003c; 0.01).</p><p>
<italic toggle="yes">&#x00394;Ee</italic>, the color difference between the esophageal squamous cell carcinoma and surrounding mucosa; iTXI, TXI image under iodine staining; iWLI, WLI image under iodine staining.</p></caption><media xlink:href="DEO2-5-e370-s001.TIF"/></supplementary-material></sec></body><back><ack id="deo2370-sec-0180"><title>ACKNOWLEDGMENTS</title><p>We thank Prof. Yuko Hashimoto of the Department of Diagnostic Pathology, Fukushima Medical University, for her diagnosis and advice on histopathological findings. Furthermore, we thank the endoscopic medical staff of the Department of Endoscopy at Fukushima Medical University Hospital for their cooperation in the endoscopic procedures.</p></ack><sec sec-type="data-availability" id="deo2370-sec-0210"><title>DATA AVAILABILITY STATEMENT</title><p>We would like to provide the data as needed.</p></sec><ref-list id="deo2370-bibl-0001"><title>REFERENCES</title><ref id="deo2370-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2370-cit-0001">
<string-name>
<surname>Arnold</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Abnet</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Neale</surname>
<given-names>RE</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Global burden of 5 major types of gastrointestinal cancer</article-title>. <source>Gastroenterology</source>
<year>2020</year>; <volume>159</volume>: <fpage>335</fpage>&#x02013;<lpage>349</lpage>.<pub-id pub-id-type="pmid">32247694</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2370-cit-0002">
<string-name>
<surname>Arnold</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Soerjomataram</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ferlay</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Forman</surname>
<given-names>D</given-names>
</string-name>. <article-title>Global incidence of oesophageal cancer by histological subtype in 2012</article-title>. <source>Gut</source>
<year>2015</year>; <volume>64</volume>: <fpage>381</fpage>&#x02013;<lpage>387</lpage>.<pub-id pub-id-type="pmid">25320104</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2370-cit-0003">
<string-name>
<surname>Ishihara</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Iishi</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Long&#x02010;term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection</article-title>. <source>Cancer</source>
<year>2008</year>; <volume>112</volume>: <fpage>2166</fpage>&#x02013;<lpage>2172</lpage>.<pub-id pub-id-type="pmid">18348303</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2370-cit-0004">
<string-name>
<surname>Yamashina</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Nagai</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Long&#x02010;term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma</article-title>. <source>Am J Gastroenterol</source>
<year>2013</year>; <volume>108</volume>: <fpage>544</fpage>&#x02013;<lpage>551</lpage>.<pub-id pub-id-type="pmid">23399555</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2370-cit-0005">
<string-name>
<surname>Hashimoto</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Iriya</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Baba</surname>
<given-names>ER</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Lugol's dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer</article-title>. <source>Am J Gastroenterol</source>
<year>2005</year>; <volume>100</volume>: <fpage>275</fpage>&#x02013;<lpage>282</lpage>.<pub-id pub-id-type="pmid">15667482</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2370-cit-0006">
<string-name>
<surname>Shimizu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Omori</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yokoyama</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic diagnosis of early squamous neoplasia of the esophagus with iodine staining: High&#x02010;grade intra&#x02010;epithelial neoplasia turns pink within a few minutes</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2008</year>; <volume>23</volume>: <fpage>546</fpage>&#x02013;<lpage>550</lpage>.<pub-id pub-id-type="pmid">17573830</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2370-cit-0007">
<string-name>
<surname>Urabe</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hiyama</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Metachronous multiple esophageal squamous cell carcinomas and lugol&#x02010;voiding lesions after endoscopic mucosal resection</article-title>. <source>Endoscopy</source>
<year>2009</year>; <volume>41</volume>: <fpage>304</fpage>&#x02013;<lpage>309</lpage>.<pub-id pub-id-type="pmid">19340732</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2370-cit-0008">
<string-name>
<surname>Katada</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tanabe</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma</article-title>. <source>Dig Endosc</source>
<year>2013</year>; <volume>25</volume> (Suppl <issue>1</issue>): <fpage>39</fpage>&#x02013;<lpage>43</lpage>.</mixed-citation></ref><ref id="deo2370-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2370-cit-0009">
<string-name>
<surname>Gruner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Denis</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Masliah</surname>
<given-names>C</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Narrow&#x02010;band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: Randomized controlled trial</article-title>. <source>Endoscopy</source>
<year>2021</year>; <volume>53</volume>: <fpage>674</fpage>&#x02013;<lpage>682</lpage>.<pub-id pub-id-type="pmid">32698233</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2370-cit-0010">
<string-name>
<surname>Nagami</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tominaga</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Machida</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>
<article-title>Usefulness of non&#x02010;magnifying narrow&#x02010;band imaging in screening of early esophageal squamous cell carcinoma: A prospective comparative study using propensity score matching</article-title>. <source>Am J Gastroenterol</source>
<year>2014</year>; <volume>109</volume>: <fpage>845</fpage>&#x02013;<lpage>854</lpage>.<pub-id pub-id-type="pmid">24751580</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo2370-cit-0011">
<string-name>
<surname>Morita</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Bernardo</surname>
<given-names>WM</given-names>
</string-name>, <string-name>
<surname>Ide</surname>
<given-names>E</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Narrow band imaging versus Lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: A systematic review and meta&#x02010;analysis</article-title>. <source>BMC Cancer</source>
<year>2017</year>; <volume>17</volume>: <fpage>54</fpage>.<pub-id pub-id-type="pmid">28086818</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo2370-cit-0012">
<string-name>
<surname>Kondo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fukuda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ono</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Sodium thiosulfate solution spray for relief of irritation caused by Lugol's stain in chromoendoscopy</article-title>. <source>Gastrointest Endosc</source>
<year>2001</year>; <volume>53</volume>: <fpage>199</fpage>&#x02013;<lpage>202</lpage>.<pub-id pub-id-type="pmid">11174292</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo2370-cit-0013">
<string-name>
<surname>Park</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>JY</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Acute esophageal and gastric injury: Complication of Lugol's solution</article-title>. <source>Scand J Gastroenterol</source>
<year>2007</year>; <volume>42</volume>: <fpage>135</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">17190773</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo2370-cit-0014">
<string-name>
<surname>Sreedharan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rembacken</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Rotimi</surname>
<given-names>O</given-names>
</string-name>. <article-title>Acute toxic gastric mucosal damage induced by Lugol's iodine spray during chromoendoscopy</article-title>. <source>Gut</source>
<year>2005</year>; <volume>54</volume>: <fpage>886</fpage>&#x02013;<lpage>887</lpage>.<pub-id pub-id-type="pmid">15888800</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo2370-cit-0015">
<string-name>
<surname>Tsurumaru</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Utsunomiya</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Matsuura</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Gastric mucosal changes caused by Lugo's iodine solution spray: Endoscopic features of 64 cases on screening esophagogastroduodenoscopy</article-title>. <source>Gastroenterol Res Pract</source>
<volume>2010</volume>; <year>2010</year>: <elocation-id>494195</elocation-id>.<pub-id pub-id-type="pmid">20396664</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo2370-cit-0016">
<string-name>
<surname>Gotoda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kanzaki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Tolerability and efficacy of the concentration of iodine solution during esophageal chromoendoscopy: A double&#x02010;blind randomized controlled trial</article-title>. <source>Gastrointest Endosc</source>
<year>2020</year>; <volume>91</volume>: <fpage>763</fpage>&#x02013;<lpage>770</lpage>.<pub-id pub-id-type="pmid">31669091</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo2370-cit-0017">
<string-name>
<surname>Sato</surname>
<given-names>T</given-names>
</string-name>. <article-title>TXI: Texture and color enhancement imaging for endoscopic image enhancement</article-title>. <source>J Healthc Eng</source>
<volume>2021</volume>; <year>2021</year>: <elocation-id>5518948</elocation-id>.<pub-id pub-id-type="pmid">33880168</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo2370-cit-0018">
<string-name>
<surname>Abe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Makiguchi</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Nonaka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yoshinaga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Emerging texture and color enhancement imaging in early gastric cancer</article-title>. <source>Dig Endosc</source>
<year>2022</year>; <volume>34</volume>: <fpage>714</fpage>&#x02013;<lpage>720</lpage>.<pub-id pub-id-type="pmid">34716942</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo2370-cit-0019">
<string-name>
<surname>Kawasaki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Nakanishi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tsuji</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takemura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Doyama</surname>
<given-names>H</given-names>
</string-name>. <article-title>Usefulness of third&#x02010;generation narrow band imaging and texture and color enhancement imaging in improving visibility of superficial early gastric cancer: A study using color difference</article-title>. <source>DEN Open</source>
<year>2023</year>; <volume>3</volume>: <elocation-id>e186</elocation-id>.<pub-id pub-id-type="pmid">36439990</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo2370-cit-0020">
<string-name>
<surname>Sugimoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Itoi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kawai</surname>
<given-names>T</given-names>
</string-name>. <article-title>Using texture and colour enhancement imaging to evaluate gastrointestinal diseases in clinical practice: A review</article-title>. <source>Ann Med</source>
<year>2022</year>; <volume>54</volume>: <fpage>3315</fpage>&#x02013;<lpage>3332</lpage>.<pub-id pub-id-type="pmid">36420822</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo2370-cit-0021">
<string-name>
<surname>Abe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamazaki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hisada</surname>
<given-names>IT</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Visibility of early gastric cancer in texture and color enhancement imaging</article-title>. <source>DEN Open</source>
<year>2021</year>; <volume>2</volume>: <elocation-id>e46</elocation-id>.<pub-id pub-id-type="pmid">35310718</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo2370-cit-0022">
<string-name>
<surname>Shijimaya</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tahara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Uragami</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Usefulness of texture and color enhancement imaging (TXI) in early gastric cancer found after Helicobacter pylori eradication</article-title>. <source>Sci Rep</source>
<year>2023</year>; <volume>13</volume>: <fpage>6899</fpage>.<pub-id pub-id-type="pmid">37106009</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo2370-cit-0023">
<string-name>
<surname>Koyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sugimoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kawai</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Visibility of early gastric cancers by texture and color enhancement imaging using a high&#x02010;definition ultrathin transnasal endoscope</article-title>. <source>Sci Rep</source>
<year>2023</year>; <volume>13</volume>: <fpage>1994</fpage>.<pub-id pub-id-type="pmid">36737509</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo2370-cit-0024">
<string-name>
<surname>Dobashi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ono</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Furuhashi</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Texture and color enhancement imaging increases color changes and improves visibility for squamous cell carcinoma suspicious lesions in the pharynx and esophagus</article-title>. <source>Diagnostics</source>
<year>2021</year>; <volume>11</volume>: <fpage>1971</fpage>.<pub-id pub-id-type="pmid">34829318</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo2370-cit-0025">
<string-name>
<surname>Kitagawa</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Esophageal cancer practice guidelines 2922 edited by the Japan esophageal society: Part 1</article-title>. <source>Esophagus</source>
<year>2023</year>; <volume>20</volume>: <fpage>343</fpage>&#x02013;<lpage>372</lpage>.<pub-id pub-id-type="pmid">36933136</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo2370-cit-0026">
<collab collab-type="authors">Japan Esophageal Society</collab>
. <article-title>Japanese classification of esophageal cancer, 11th ed</article-title>. <source>Esophagus</source>
<year>2017</year>; <volume>14</volume>: <fpage>1</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">28111535</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo2370-cit-0027">
<string-name>
<surname>Mokrzycki</surname>
<given-names>WS</given-names>
</string-name>, <string-name>
<surname>Tatol</surname>
<given-names>M</given-names>
</string-name>. <article-title>Colour difference &#x00394;E &#x02013; A survey</article-title>. <source>Mach Graph Vis Int J</source>
<year>2011</year>; <volume>20</volume>: <fpage>383</fpage>&#x02013;<lpage>411</lpage>.</mixed-citation></ref><ref id="deo2370-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo2370-cit-0028">
<string-name>
<surname>Yoshida</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Dohi</surname>
<given-names>O</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Analysis of texture and color enhancement imaging for improving the visibility of non&#x02010;polypoid colorectal lesions</article-title>. <source>Dig Dis Sci</source>
<year>2022</year>; <volume>67</volume>: <fpage>5657</fpage>&#x02013;<lpage>5665</lpage>.<pub-id pub-id-type="pmid">35318554</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="deo2370-cit-0029">
<string-name>
<surname>Toyoshima</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Nishizawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Texture and color enhancement imaging in magnifying endoscopic evaluation of colorectal adenomas</article-title>. <source>World J Gastrointest Endosc</source>
<year>2022</year>; <volume>14</volume>: <fpage>96</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">35316981</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="deo2370-cit-0030">
<string-name>
<surname>Sakamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ikematsu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tamai</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Detection of colorectal adenomas with texture and color enhancement imaging: Multicenter observational study</article-title>. <source>Dig Endosc</source>
<year>2023</year>; <volume>35</volume>: <fpage>529</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">36398944</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="deo2370-cit-0031">
<string-name>
<surname>Okimoto</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Matsumura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Maruoka</surname>
<given-names>D</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Magnified endoscopy with texture and color enhanced imaging with indigo carmine for superficial nonampullary duodenal tumor: A pilot study</article-title>. <source>Sci Rep</source>
<year>2022</year>; <volume>12</volume>: <elocation-id>10381</elocation-id>.<pub-id pub-id-type="pmid">35725752</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="deo2370-cit-0032">
<string-name>
<surname>Sugimoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kawai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Akimoto</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Third&#x02010;generation high&#x02010;vision ultrathin endoscopy using texture and color enhancement imaging and narrow&#x02010;band imaging to evaluate Barrett's esophagus</article-title>. <source>Diagnostics</source>
<year>2022</year>; <volume>12</volume>: <fpage>3149</fpage>.<pub-id pub-id-type="pmid">36553156</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="deo2370-cit-0033">
<string-name>
<surname>Ikeda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Takeda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ueyama</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Comparison of texture and color enhancement imaging with white light imaging in 52 patients with short&#x02010;segment Barrett's esophagus</article-title>. <source>Med Sci Monit</source>
<year>2023</year>; <volume>29</volume>: <elocation-id>e940249</elocation-id>.<pub-id pub-id-type="pmid">37309104</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="deo2370-cit-0034">
<string-name>
<surname>Kawada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Arima</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Miyahara</surname>
<given-names>R</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Effect of adding magnifying BLI, magnifying NBI, and iodine staining to white light imaging in diagnosis of early esophageal cancer</article-title>. <source>Endosc Int Open</source>
<year>2021</year>; <volume>9</volume>: <fpage>E1877</fpage>&#x02013;<lpage>1885</lpage>.<pub-id pub-id-type="pmid">34917456</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="deo2370-cit-0035">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Lugol chromoendoscopy detects esophageal dysplasia with low levels of sensitivity in a high&#x02010;risk region of China</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2018</year>; <volume>16</volume>: <fpage>1585</fpage>&#x02013;<lpage>1592</lpage>.<pub-id pub-id-type="pmid">29174712</pub-id>
</mixed-citation></ref><ref id="deo2370-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="deo2370-cit-0036">
<string-name>
<surname>Ide</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Carneiro</surname>
<given-names>FO</given-names>
</string-name>, <string-name>
<surname>Fraz&#x000e3;o</surname>
<given-names>MS</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic detection of early esophageal squamous cell carcinoma in patients with achalasia: Narrow&#x02010;band imaging versus lugol's staining</article-title>. <source>J Oncol</source>
<volume>2013</volume>; <year>2013</year>: <elocation-id>736756</elocation-id>.<pub-id pub-id-type="pmid">23935622</pub-id>
</mixed-citation></ref></ref-list></back></article>